Skip to content

Clinical trials

Completed Phase 3 Connective Tissue Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Connective Tissue Diseases Phase: Phase 3 Status: Completed Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20102
20111
20161
20171
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
National Center for Research Resources (NCRR)2
Amgen1
AstraZeneca1
Encysive Pharmaceuticals1
Liquidia Technologies, Inc.1
Philips Healthcare1
State University of New York1
United Therapeutics1
University Hospital, Tours1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Connective Tissue Diseases12
Arthritis4
Immune System Diseases4
Autoimmune Diseases3
Lupus Erythematosus, Systemic3
Pulmonary Arterial Hypertension3
Rare Diseases3
Familial Primary Pulmonary Hypertension2
Hypertension, Pulmonary2
Respiratory Tract Diseases2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.